{"id":784108,"date":"2023-09-14T12:06:50","date_gmt":"2023-09-14T16:06:50","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/"},"modified":"2023-09-14T12:06:50","modified_gmt":"2023-09-14T16:06:50","slug":"gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/","title":{"rendered":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN DIEGO and SUZHOU,\u00a0China and SHANGHAI, China, Sept.  14, 2023  (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences.<\/p>\n<p>\n        <strong>Stifel 2023 Immunology and Inflammation Virtual Summit <\/strong><br \/>\n        <br \/>Fireside Chat: Wednesday, September 20<sup>th<\/sup> at 10:15 am ET<br \/>Presenter: Dr. Kevin Xie, Chief Financial Officer<br \/>Location: Virtual<\/p>\n<p>\n        <strong>Jefferies Cell &amp; Genetic Medicine Summit<\/strong><br \/>\n        <br \/>Fireside Chat: Tuesday, September 26<sup>th<\/sup> at 9:00 am ET<br \/>One-on-one meetings: September 26<sup>th<\/sup>, 2023<br \/>Presenter: Dr. Kevin Xie, Chief Financial Officer<br \/>Location: New York<\/p>\n<p>\n        <strong>2023 Cantor Global Healthcare Conference<\/strong><br \/>\n        <br \/>Presentation: Wednesday, September 27<sup>th <\/sup>at 9:10 am ET<br \/>One-on-one meetings: September 27<sup>th<\/sup>, 2023<br \/>Presenter: Dr. Kevin Xie, Chief Financial Officer<br \/>Location: New York<\/p>\n<p align=\"justify\">Webcast of the presentations will be available on the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rJlE4It_PNXZFzYF9O6HAvshaWOiPuQl7zKDpgcHcxlHCE7MC0wUdUiNy5EzVVUDAJifVampyh4xCV5-BYmBjRVQwQuYkXi-KDFQmd8pWfEkhfedZc49ZOOQFQ69ZYHVf_-uCzWoMJ6S8Dj3KqSRZg==\" rel=\"nofollow noopener\" target=\"_blank\">News and Events<\/a> section of Gracell\u2019s investor website. A replay of the webcast will be available for 30 days following the event.<\/p>\n<p align=\"justify\">\n        <strong>About Gracell <\/strong><br \/>\n        <br \/>Gracell Biotechnologies Inc. (\u201cGracell\u201d) is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies for the treatment of cancers and autoimmune diseases. Leveraging its innovative FasTCAR and TruUCAR technology platforms and SMART CAR\u2122 technology module, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal cell quality, high therapy cost, and lack of effective CAR-T therapies for solid tumors and autoimmune diseases. The lead candidate BCMA\/CD19 dual-targeting FasTCAR-T GC012F is currently being evaluated in clinical studies for the treatment of multiple myeloma, B-cell non-Hodgkin&#8217;s lymphoma and systemic lupus erythematosus (SLE). For more information on Gracell, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BXHzKJGFrmfkc9AFA5yl7wNo-Pt3wFhyw29W1zCtMBwLetA3szrE15o7Cgd2SQXRbeyMqEHYKf7yW9nXdFXRbUt_JoUJZqEtXOOaeAQZlxc=\" rel=\"nofollow noopener\" target=\"_blank\">www.gracellbio.com<\/a>.\u00a0Follow @GracellBio on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E3pKLroSdxyqrgFrPc1AiucF-3j1DDV1bTNLtzHyxnPEHmODCkEytsxYmuSl7m4R_rnkbmVM0s2qvL19Ohc0AQL8Eb9_f10rKUEhNcPKPVw=\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/N2JjMjczNWItZDhmOS00NTdmLTllYTgtZjY3NTExM2QwODM0LTEyMTU4Mzk=\/tiny\/Gracell-Biotechnologies-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Media contact\r\nMarvin Tang\r\nmarvin.tang@gracellbio.com\r\n\r\nInvestor contact\r\nGracie Tong\r\ngracie.tong@gracellbio.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN DIEGO and SUZHOU,\u00a0China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences. Stifel 2023 Immunology and Inflammation Virtual Summit Fireside Chat: Wednesday, September 20th at 10:15 am ETPresenter: Dr. Kevin Xie, Chief Financial OfficerLocation: Virtual Jefferies Cell &amp; Genetic Medicine Summit Fireside Chat: Tuesday, September 26th at 9:00 am ETOne-on-one meetings: September 26th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York 2023 Cantor Global Healthcare Conference Presentation: Wednesday, September 27th at 9:10 am &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-784108","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO and SUZHOU,\u00a0China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences. Stifel 2023 Immunology and Inflammation Virtual Summit Fireside Chat: Wednesday, September 20th at 10:15 am ETPresenter: Dr. Kevin Xie, Chief Financial OfficerLocation: Virtual Jefferies Cell &amp; Genetic Medicine Summit Fireside Chat: Tuesday, September 26th at 9:00 am ETOne-on-one meetings: September 26th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York 2023 Cantor Global Healthcare Conference Presentation: Wednesday, September 27th at 9:10 am &hellip; Continue reading &quot;Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-14T16:06:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences\",\"datePublished\":\"2023-09-14T16:06:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/\",\"name\":\"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\",\"datePublished\":\"2023-09-14T16:06:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/","og_locale":"en_US","og_type":"article","og_title":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk","og_description":"SAN DIEGO and SUZHOU,\u00a0China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) &#8212; Gracell Biotechnologies Inc. (NASDAQ: GRCL) (\u201cGracell\u201d), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences. Stifel 2023 Immunology and Inflammation Virtual Summit Fireside Chat: Wednesday, September 20th at 10:15 am ETPresenter: Dr. Kevin Xie, Chief Financial OfficerLocation: Virtual Jefferies Cell &amp; Genetic Medicine Summit Fireside Chat: Tuesday, September 26th at 9:00 am ETOne-on-one meetings: September 26th, 2023Presenter: Dr. Kevin Xie, Chief Financial OfficerLocation: New York 2023 Cantor Global Healthcare Conference Presentation: Wednesday, September 27th at 9:10 am &hellip; Continue reading \"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/","og_site_name":"Market Newsdesk","article_published_time":"2023-09-14T16:06:50+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences","datePublished":"2023-09-14T16:06:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/","name":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=","datePublished":"2023-09-14T16:06:50+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODkyMjM4MiM1ODE0OTc4IzIyMDQyODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/gracell-biotechnologies-to-participate-in-three-upcoming-investor-conferences-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784108","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=784108"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/784108\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=784108"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=784108"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=784108"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}